Author： Cocquyt Veronique Schelfhout Vera Blondeel Phillip Depypere Herman Daems Kristof Serreyn Rudolphe Praet Marleen Beele Simon
Publisher： Humana Press, Inc
ISSN： 1357-0560
Source： Medical Oncology, Vol.20, Iss.3, 2003-09, pp. : 221-231
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Prediction of response to primary chemotherapy for operable breast cancer
By Colleoni M. Orvieto E. Nole Orlando L. Minchella I. Viale G. Peruzzotti G. Robertson C. Noberasco C. Galimberti V. Sacchini V. Veronesi P. Zurrida S. Orecchia R. Goldhirsch A.
European Journal of Cancer, Vol. 35, Iss. 4, 1999-04 ,pp. :
Access to resources
Recommend
Breast Cancer: The Value of Preoperative Chemotherapy
American Journal of Cancer, Vol. 1, Iss. 2, 2002-02 ,pp. :
By Collecchi P. Baldini E. Giannessi P. Naccarato A.G. Passoni A. Gardin G. Roncella M. Evangelista G. Bevilacqua G. Conte P.F.
European Journal of Cancer, Vol. 34, Iss. 11, 1998-10 ,pp. :
Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancer
By Martin M. Romero A. Cheang M. López García-Asenjo J. García-Saenz J. Oliva B. Román J. He X. Casado A. Torre J. Furio V. Puente J. Caldés T. Vidart J. Lopez-Tarruella Sara Diaz-Rubio E. Perou C.
Breast Cancer Research and Treatment, Vol. 128, Iss. 1, 2011-07 ,pp. :